Tertiary lymphoid organs: A novel target in patients with chronic rhinosinusitis - 06/11/18
Doi : 10.1016/j.jaci.2018.07.024
Sathish Paramasivan, MBBS, BMedSci(Hons), MPH a, Susan Lester, BSc(Hons) b, c, Aden Lau, MBiS, BSc a, Judy Ou, MBBS, BSc a, Alkis James Psaltis, MBBS(Hons), PhD, FRACS a, Peter-John Wormald, MD, FRACS a, Sarah Vreugde, MD, PhD a 
a Department of Surgery–Otolaryngology, Head and Neck Surgery, Adelaide, Australia
b Discipline of Medicine, University of Adelaide, Adelaide, Australia
c Rheumatology Department, Queen Elizabeth Hospital, Woodville, Australia
| Supported by a Garnett Passe and Rodney Williams Memorial Foundation Academic Surgeon Scientist Research Scholarship (ASSRS; to S.P.). |
|
| Disclosure of potential conflict of interest: S. Paramasivan is supported by a Garnett Passe and Rodney Williams Memorial Foundation Academic Surgeon Scientist Research Scholarship (ASSRS). A. J. Psaltis is a consultant with ENT Technologies and Aerin Technologies and is on the speakers' bureau for Smith and Nephew. P.-J. Wormald is a consultant with ENT Technologies, received royalties from the sale of surgical equipment from Medtronic, and is supported by a bequest donation to the University of Adelaide from the estate of the late Yvonne Carna Laura Ives Thomas. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 142 - N° 5
P. 1673-1676 - novembre 2018 Retour au numéro
Article précédent
- Glucocorticoids promote intrinsic human TH17 differentiation
- Juliana de Castro Kroner, Kristin Knoke, David M. Kofler, Julia Steiger, Mario Fabri
- Is substance P a nasal epithelial neuropeptide?
- Steven D. Douglas, Susan E. Leeman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?